Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1354-1361

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collet, J. P.
Right arrow Articles by Weisel, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collet, J. P.
Right arrow Articles by Weisel, J. W.
Related Collections
Right arrow Fibrinolysis
Right arrow Coagulation and fibronolysis
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1354.)
© 2000 American Heart Association, Inc.


Thrombosis

Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis Speed

Dynamic and Structural Approaches by Confocal Microscopy

Presented in part as an abstract at the meeting of the International Society of Thrombosis and Haemostasis, August 16 to 20, Washington, DC, 1999.

J. P. Collet; D. Park; C. Lesty; J. Soria; C. Soria; G. Montalescot; J. W. Weisel

From the Department of Cardiology (J.P.C., G.M.) and the Hemostasis Laboratory (C.L.), Pitié-Salpétrière Hospital, and the Research Laboratory Sainte Marie (J.S., C.S.), Hotel Dieu Hospital, Paris, France, and the Department of Cell and Developmental Biology (J.P.C., D.P., J.W.W.), University of Pennsylvania, Philadelphia.

Correspondence to J.P. Collet, MD, PhD, Department of Cardiology, Centre Hospitalier Universitaire Pitié-Salpétrière, 47, boulevard de l’Hôpital, 75013 Paris, France. E-mail jean-philippe.collet{at}psl.ap-hop-paris.fr

Abstract—Abnormal fibrin architecture is thought to be a determinant factor of hypofibrinolysis. However, because of the lack of structural knowledge of the process of fibrin digestion, relationships between fibrin architecture and hypofibrinolysis remain controversial. To elucidate further structural and dynamic changes occurring during fibrinolysis, cross-linked plasma fibrin was labeled with colloidal gold particles, and fibrinolysis was followed by confocal microscopy. Morphological changes were characterized at fibrin network and fiber levels. The observation of a progressive disaggregation of the fibrin fibers emphasizes that fibrinolysis proceeds by transverse cutting rather than by progressive cleavage uniformly around the fiber. Plasma fibrin clots with a tight fibrin conformation made of thin fibers were dissolved at a slower rate than those with a loose fibrin conformation made of thicker (coarse) fibers, although the overall fibrin content remained constant. Unexpectedly, thin fibers were cleaved at a faster rate than thick ones. A dynamic study of FITC–recombinant tissue plasminogen activator distribution within the fibrin matrix during the course of fibrinolysis showed that the binding front was broader in coarse fibrin clots and moved more rapidly than that of fine plasma fibrin clots. These dynamic and structural approaches to fibrin digestion at the network and the fiber levels reveal aspects of the physical process of clot lysis. Furthermore, these results provide a clear explanation for the hypofibrinolysis related to a defective fibrin architecture as described in venous thromboembolism and in premature coronary artery disease.


Key Words: fibrin • fibrinolysis • confocal microscopy




This article has been cited by other articles:


Home page
ScienceHome page
A. E. X. Brown, R. I. Litvinov, D. E. Discher, P. K. Purohit, and J. W. Weisel
Multiscale Mechanics of Fibrin Polymer: Gel Stretching with Protein Unfolding and Loss of Water
Science, August 7, 2009; 325(5941): 741 - 744.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R.A. Ajjan, K.F. Standeven, M. Khanbhai, F. Phoenix, K.C. Gersh, J.W. Weisel, M.T. Kearney, R.A.S. Ariens, and P.J. Grant
Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 712 - 717.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M.K. Williams, A. M. Carter, B. Kato, M. Falchi, L. Bathum, G. Surdulescu, K. O. Kyvik, A. Palotie, T. D. Spector, P. J. Grant, et al.
Identification of Quantitative Trait Loci for Fibrin Clot Phenotypes: The EuroCLOT Study
Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 600 - 605.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. I. Tucker, U. M. Marzec, T. C. White, S. Hurst, S. Rugonyi, O. J. T. McCarty, D. Gailani, A. Gruber, and S. R. Hanson
Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
Blood, January 22, 2009; 113(4): 936 - 944.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. A. Campbell, K. A. Overmyer, C. R. Bagnell, and A. S. Wolberg
Cellular Procoagulant Activity Dictates Clot Structure and Stability as a Function of Distance From the Cell Surface
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2247 - 2254.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
D. K. Galanakis, M. Neerman-Arbez, A. Henschen, and B. Kudryk
Enhanced Fibrinolysis of Coarse Fibrin Networks Reflects Cleavage of a B Knob Containing Fragment(s)
Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 1019 - 1019.
[Abstract]


Home page
Nephrol Dial TransplantHome page
A. Undas, M. Kolarz, G. Kopec, and W. Tracz
Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 2010 - 2015.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Ajjan, B. C. B. Lim, K. F. Standeven, R. Harrand, S. Dolling, F. Phoenix, R. Greaves, R. H. Abou-Saleh, S. Connell, D. A. M. Smith, et al.
Common variation in the C-terminal region of the fibrinogen -chain: effects on fibrin structure, fibrinolysis and clot rigidity
Blood, January 15, 2008; 111(2): 643 - 650.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. M. Carter, C. M. Cymbalista, T. D. Spector, P. J. Grant, and on behalf of the EuroCLOT Investigators
Heritability of Clot Formation, Morphology, and Lysis: The EuroCLOT Study
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2783 - 2789.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. A. Dugan, V. W.-C. Yang, D. J. McQuillan, and M. Hook
Decorin Modulates Fibrin Assembly and Structure
J. Biol. Chem., December 15, 2006; 281(50): 38208 - 38216.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Silveira and A. Hamsten
Fibrin gel architecture influences endogenous fibrinolysis and may promote coronary artery disease.
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2419 - 2420.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.P. Collet, Y. Allali, C. Lesty, M.L. Tanguy, J. Silvain, A. Ankri, B. Blanchet, R. Dumaine, J. Gianetti, L. Payot, et al.
Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis
Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2567 - 2573.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Undas, J. Brozek, M. Jankowski, Z. Siudak, A. Szczeklik, and H. Jakubowski
Plasma Homocysteine Affects Fibrin Clot Permeability and Resistance to Lysis in Human Subjects
Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1397 - 1404.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-P. Collet, J. L. Moen, Y. I. Veklich, O. V. Gorkun, S. T. Lord, G. Montalescot, and J. W. Weisel
The {alpha}C domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis
Blood, December 1, 2005; 106(12): 3824 - 3830.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. R. Siebenlist, M. W. Mosesson, I. Hernandez, L. A. Bush, E. Di Cera, J. R. Shainoff, J. P. Di Orio, and L. Stojanovic
Studies on the basis for the properties of fibrin produced from fibrinogen-containing {gamma}' chains
Blood, October 15, 2005; 106(8): 2730 - 2736.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-P. Collet, H. Shuman, R. E. Ledger, S. Lee, and J. W. Weisel
The elasticity of an individual fibrin fiber in a clot
PNAS, June 28, 2005; 102(26): 9133 - 9137.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. M. Scott, R. A.S. Ariens, and P. J. Grant
Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease
Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1558 - 1566.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-P. Wu, H. J. Bloemendal, E. E. Voest, T. Logtenberg, P. G. de Groot, M. F. B. G. Gebbink, and H. C. de Boer
Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin
Blood, August 15, 2004; 104(4): 1034 - 1041.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Vadseth, J. M. Souza, L. Thomson, A. Seagraves, C. Nagaswami, T. Scheiner, J. Torbet, G. Vilaire, J. S. Bennett, J.-C. Murciano, et al.
Pro-thrombotic State Induced by Post-translational Modification of Fibrinogen by Reactive Nitrogen Species
J. Biol. Chem., March 5, 2004; 279(10): 8820 - 8826.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. J. Dunn, R. A. Ariens, M. de Lange, H. Snieder, J. H. Turney, T. D. Spector, and P. J. Grant
Genetics of fibrin clot structure: a twin study
Blood, March 1, 2004; 103(5): 1735 - 1740.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.P. Collet, C. Nagaswami, D.H. Farrell, G. Montalescot, and J.W. Weisel
Influence of {gamma}' Fibrinogen Splice Variant on Fibrin Physical Properties and Fibrinolysis Rate
Arterioscler Thromb Vasc Biol, February 1, 2004; 24(2): 382 - 386.
[Abstract] [Full Text]


Home page
StrokeHome page
F. Niessen, T. Hilger, M. Hoehn, and K.-A. Hossmann
Differences in Clot Preparation Determine Outcome of Recombinant Tissue Plasminogen Activator Treatment in Experimental Thromboembolic Stroke
Stroke, August 1, 2003; 34(8): 2019 - 2024.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. V. Cooper, K. F. Standeven, and R. A. S. Ariens
Fibrinogen gamma-chain splice variant {gamma}' alters fibrin formation and structure
Blood, July 15, 2003; 102(2): 535 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Lian, S. J. Szarka, K. K. S. Ng, and S.-L. Wong
Engineering of a Staphylokinase-based Fibrinolytic Agent with Antithrombotic Activity and Targeting Capability toward Thrombin-rich Fibrin and Plasma Clots
J. Biol. Chem., July 11, 2003; 278(29): 26677 - 26686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-P. Collet, C. Lesty, G. Montalescot, and J. W. Weisel
Dynamic Changes of Fibrin Architecture during Fibrin Formation and Intrinsic Fibrinolysis of Fibrin-rich Clots
J. Biol. Chem., June 6, 2003; 278(24): 21331 - 21335.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. S. Wolberg, D. M. Monroe, H. R. Roberts, and M. Hoffman
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk
Blood, April 15, 2003; 101(8): 3008 - 3013.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. D. Mills, R. A.S. Ariens, M. W. Mansfield, and P. J. Grant
Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease
Circulation, October 8, 2002; 106(15): 1938 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.Ph. Collet, G. Montalescot, C. Lesty, and J.W. Weisel
A Structural and Dynamic Investigation of the Facilitating Effect of Glycoprotein IIb/IIIa Inhibitors in Dissolving Platelet-Rich Clots
Circ. Res., March 8, 2002; 90(4): 428 - 434.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. B. Hotary, I. Yana, F. Sabeh, X.-Y. Li, K. Holmbeck, H. Birkedal-Hansen, E. D. Allen, N. Hiraoka, and S. J. Weiss
Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP-dependent and -independent Processes
J. Exp. Med., January 28, 2002; 195(3): 295 - 308.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.Ph. Collet, G. Montalescot, C. Lesty, and J.W. Weisel
A Structural and Dynamic Investigation of the Facilitating Effect of Glycoprotein IIb/IIIa Inhibitors in Dissolving Platelet-Rich Clots
Circ. Res., March 8, 2002; 90(4): 428 - 434.
[Abstract] [Full Text] [PDF]